Cargando…
The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
The antitumour agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) was found to inhibit competitively the low-Km cyclic AMP phosphodiesterase activity in an ammonium-sulphate-precipitable fraction of the 2,000g supernatant of rat liver. With substrate concentration at 0.25 microM, I50 wa...
Autores principales: | Larsson, P. G., Haffner, F., Brłnstad, G. O., Christoffersen, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010101/ https://www.ncbi.nlm.nih.gov/pubmed/228692 |
Ejemplares similares
-
Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma
por: Yang, Xi, et al.
Publicado: (2010) -
Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.
por: Lunn, J. M., et al.
Publicado: (1988) -
Phosphodiesterases and cAMP Pathway in Pituitary Diseases
por: Bizzi, Mariana Ferreira, et al.
Publicado: (2019) -
An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing
por: Johnson, Keven R, et al.
Publicado: (2010) -
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases
por: Park, Sung-Jun, et al.
Publicado: (2012)